Cargando…

First insights into the phylogenetic diversity of Mycobacterium tuberculosis in Kuwait and evaluation of REBA MTB-MDR assay for rapid detection of MDR-TB

Early detection of Mycobacterium tuberculosis (Mtb) in clinical specimens, its susceptibility to anti-TB drugs and disruption of infection transmission to new hosts are essential components for global tuberculosis (TB) control efforts. This study investigated major Mtb genotypes circulating in Kuwai...

Descripción completa

Detalles Bibliográficos
Autores principales:	Al-Mutairi, Noura M., Ahmad, Suhail, Mokaddas, Eiman, Al-Hajoj, Sahal
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9584360/ https://www.ncbi.nlm.nih.gov/pubmed/36264939 http://dx.doi.org/10.1371/journal.pone.0276487

Ejemplares similares

759. Molecular Characterization and Epidemiology of Multidrug-Resistant Mycobacterium tuberculosis (MDR-TB) and Identification of Possible Cases of Local Transmission of MDR-TB in Kuwait
por: Mokaddas, Eiman, et al.
Publicado: (2018)

Molecular characterization of multidrug-resistant Mycobacterium tuberculosis (MDR-TB) isolates identifies local transmission of infection in Kuwait, a country with a low incidence of TB and MDR-TB
por: Al-Mutairi, Noura M., et al.
Publicado: (2019)

Correction to: Molecular characterization of multidrug-resistant Mycobacterium tuberculosis (MDR-TB) isolates identifies local transmission of infection in Kuwait, a country with a low incidence of TB and MDR-TB
por: Al-Mutairi, Noura M., et al.
Publicado: (2020)

Increasing prevalence of resistance to second-line drugs among multidrug-resistant Mycobacterium tuberculosis isolates in Kuwait
por: Al-Mutairi, Noura M., et al.
Publicado: (2021)

First report of molecular detection of fluoroquinolone resistance-associated gyrA mutations in multidrug-resistant clinical Mycobacterium tuberculosis isolates in Kuwait
por: Al-Mutairi, Noura M, et al.
Publicado: (2011)

Variations in the occurrence of specific rpoB mutations in rifampicin-resistant Mycobacterium tuberculosis isolates from patients of different ethnic groups in Kuwait
por: Ahmad, Suhail, et al.
Publicado: (2012)

Performance of the Genotype MTBDR assay for molecular detection of multidrug-resistant strains of Mycobacterium tuberculosis
por: Al-Mutairi, Noura, et al.
Publicado: (2008)

Discordance across Phenotypic and Molecular Methods for Drug Susceptibility Testing of Drug-Resistant Mycobacterium tuberculosis Isolates in a Low TB Incidence Country
por: Ahmad, Suhail, et al.
Publicado: (2016)

Comparative accuracy of the REBA MTB MDR and Hain MTBDRplus line probe assays for the detection of multidrug-resistant tuberculosis: A multicenter, non-inferiority study
por: Havumaki, Joshua, et al.
Publicado: (2017)

Utility of the REBA MTB-rifa® assay for rapid detection of rifampicin resistant Mycobacterium Tuberculosis
por: Cho, Eunjin, et al.
Publicado: (2013)

Minor contribution of mutations at iniA codon 501 and embC-embA intergenic region in ethambutol-resistant clinical Mycobacterium tuberculosis isolates in Kuwait
por: Jaber, Al-Anoud, et al.
Publicado: (2009)

Occurrence of disputed rpoB mutations among Mycobacterium tuberculosis isolates phenotypically susceptible to rifampicin in a country with a low incidence of multidrug-resistant tuberculosis
por: Al-Mutairi, Noura M., et al.
Publicado: (2019)

Molecular fingerprinting reveals familial transmission of rifampin-resistant tuberculosis in Kuwait
por: Mokaddas, Eiman, et al.
Publicado: (2005)

‘Z(S)-MDR-TB' versus ‘Z(R)-MDR-TB': improving treatment of MDR-TB by identifying pyrazinamide susceptibility
por: Zhang, Ying, et al.
Publicado: (2012)

Drug Susceptibility of Mycobacterium tuberculosis Beijing Genotype and Association with MDR TB
por: de Steenwinkel, Jurriaan E.M., et al.
Publicado: (2012)

Evaluation of Xpert MTB/RIF Assay, MTB Culture and Line Probe Assay for the Detection of MDR Tuberculosis in AFB Smear Negative Specimens
por: Lama, Chandri, et al.
Publicado: (2022)

MDR TB Transmission, Singapore
por: Chee, Cynthia B.E., et al.
Publicado: (2013)

Rapid diagnosis of MDR and XDR tuberculosis with the MeltPro TB assay in China
por: Pang, Yu, et al.
Publicado: (2016)

Community-based MDR-TB care project improves treatment initiation in patients diagnosed with MDR-TB in Myanmar
por: Wai, Pyae Phyo, et al.
Publicado: (2018)

Predictors of Multidrug-Resistant Tuberculosis (MDR-TB) in Sudan
por: Ali, Monadil H., et al.
Publicado: (2019)

Simultaneous detection of Mycobacterium tuberculosis complex and resistance to Rifampicin and Isoniazid by MDR/MTB ELITe MGB(®) Kit for the diagnosis of tuberculosis
por: Bisognin, Francesco, et al.
Publicado: (2020)

Prevalence and Factors Associated with Multidrug-Resistant Tuberculosis (MDR-TB) among Presumptive MDR-TB Patients in Tigray Region, Northern Ethiopia
por: Mehari, Kibriti, et al.
Publicado: (2019)

Rapid Molecular Diagnosis of Tuberculosis and Its Resistance to Rifampicin and Isoniazid with Automated MDR/MTB ELITe MGB(®) Assay
por: Ok, Vichita, et al.
Publicado: (2021)

Genome sequencing and annotation of multidrug resistant Mycobacterium tuberculosis (MDR-TB) PR10 strain
por: Halim, Mohd Zakihalani A., et al.
Publicado: (2016)

T CELL EPITOPES OF THE ESXA FULL GENE OF MYCOBACTERIUM TUBERCULOSIS FROM SPUTUM OF MDR-TB PATIENTS
por: Dewi, Desak Nyoman Surya Suameitria, et al.
Publicado: (2018)

Analysis of multi drug resistant tuberculosis (MDR-TB) financial protection policy: MDR-TB health insurance schemes, in Chhattisgarh state, India
por: Kundu, Debashish, et al.
Publicado: (2018)

Collaborative public–private initiatives targeting multidrug-resistant tuberculosis (MDR-TB) supported by the Lilly MDR-TB Partnership: experiences in 2012–2016
por: Shelby, Peter W, et al.
Publicado: (2017)

Management of MDR-TB: Review of Iran's Experience
por: Masjedi, Mohammad Reza, et al.
Publicado: (2013)

MDR-TB in Pakistan: Challenges, efforts, and recommendations
por: Khan, Mahad Ahmed, et al.
Publicado: (2022)

Issues in design and interpretation of MDR-TB clinical trials: report of the first Global MDR-TB Clinical Trials Landscape Meeting
por: Mitnick, Carole D, et al.
Publicado: (2015)

Epidemiology of Candidemia in Kuwait: A Nationwide, Population-Based Study
por: Alobaid, Khaled, et al.
Publicado: (2021)

1689 Performance Comparison of Two Commercial Tests for Rapid Molecular Diagnosis of Exprapulmonary Tuberculosis in a Low TB Incidence Country
por: Mokaddas, Eiman, et al.
Publicado: (2014)

Prospective evaluation of simply modified MODS assay: an effective tool for TB diagnosis and detection of MDR-TB
por: Chaiyasirinroje, Boonchai, et al.
Publicado: (2012)

Early detection of MDR Mycobacterium tuberculosis mutations in Pakistan
por: Aftab, Ayma, et al.
Publicado: (2021)

The Performance of the Abbott Real Time MTB RIF/INH Compared to the MTBDRplus V2 for the Identification of MDR-TB Among Isolates
por: David, Anura, et al.
Publicado: (2020)

Adverse Events in Healthy Individuals and MDR-TB Contacts Treated with Anti-Tuberculosis Drugs Potentially Effective for Preventing Development of MDR-TB: A Systematic Review
por: Langendam, Miranda W., et al.
Publicado: (2013)

A pre-clinical validation plan to evaluate analytical sensitivities of molecular diagnostics such as BD MAX MDR-TB, Xpert MTB/Rif Ultra and FluoroType MTB
por: Beutler, Markus, et al.
Publicado: (2020)

Low-dose amikacin in the treatment of Multidrug-resistant Tuberculosis (MDR-TB)
por: Sabur, Natasha F., et al.
Publicado: (2021)

Rapid screening of MDR-TB using molecular Line Probe Assay is feasible in Uganda
por: Albert, Heidi, et al.
Publicado: (2010)

Why has MDR-TB prevalence increased in Iran?
por: Heidary, Mohsen, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_dpggipugr488vma79dbeo23dh5